Valor Health Critical Access Hospital (Medicare Certified) Location: 1202 East Locust Street, Emmett, Idaho 83617 Ratings:NA Phone: (208) 365-3561 |
News Archive
The peer-reviewed results of the first trial of the effect of male circumcision on HIV infection, which some experts call "a landmark trial," will be published in PLoS Medicine on October 25. The trial found that circumcision reduced the rate of new infections among heterosexual men in South Africa by about 60%.
NexBio, Inc. announced today the initiation of a trial of DAS181 (FludaseĀ®) in patients with the respiratory conditions asthma and bronchiectasis, being conducted by researchers with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This trial will examine the effects of DAS181 in subjects with well-controlled or stable pulmonary disease.
The Canadian Diabetes Association applauds the Government of Saskatchewan for increasing access to insulin detemir for residents of Saskatchewan living with diabetes. Insulin detemir, also known as Levemir, has been added to the Saskatchewan Drug Formulary, under Exception Drug Status (EDS) effective July 1, 2009. As well, the updated formulary now includes NovoRapid-NOO, Apidra-AVT and Humalog-LIL within its Revised Exception Drug Status Criteria.
In a post on IntraHealth's "Global Health Blog," Rebecca Kohler, senior vice president of corporate strategy and development at IntraHealth, writes about an event held last week on the sidelines of the Democratic National Convention (DNC) that "focused on the vital role of women's health in foreign policy."
› Verified 9 days ago